US · Healthcare

Tonix Pharmaceuticals Holding Corp (TNXP)

Biotechnology

Tonix Pharmaceuticals Holding Corp (TNXP) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for TNXP

P/E ratio

25.00

Tonix Pharmaceuticals Holding Corp (TNXP) — FAQ

What is TNXP's P/E ratio?

The price-to-earnings (P/E) ratio for Tonix Pharmaceuticals Holding Corp (TNXP) is 25.00 (data as of 2026-05-23).

Does Tonix Pharmaceuticals Holding Corp pay a dividend?

Dividend yield is not available in the current snapshot for Tonix Pharmaceuticals Holding Corp (TNXP). Check the MyAverix Finance app for the latest dividend data.

What sector is Tonix Pharmaceuticals Holding Corp in?

Tonix Pharmaceuticals Holding Corp (TNXP) is classified in the Healthcare sector (Biotechnology industry).

What exchange is TNXP listed on?

TNXP is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)